PATENT CLAIM ANALYSIS

Application Number: 16233507
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-09
Patent Classification: ["514", "256000"]

Abstract:
The present invention relates to compounds according to Formula (I): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof wherein X 1 , X 2 , R 1 , R 2 , R 3  and n are as defined herein. Also described are pharmaceutically acceptable compositions of Formula (I) compounds as well as methods for utilizing the compounds of Formula (I) and the pharmaceutically acceptable compositions of Formula (I) compounds as inhibitors of Mnk as well as therapeutics for the treatment of diseases such as cancer.

Claim (Index 16):
The compound or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof according to  claim 1  selected from compounds 3D, 3K, 3L, 3X, 3Y, rac-1F, 1Fa, 1Fb, rac-2F, 2Fa and 2Fb.

Metadata:
- Claim Count in Document: 48.0
- Percentile: 98.0
- Lexical Diversity: 1.96
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15187854', '14748990', '15611966', '15337184', '15355271']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8408150217493856
- 35 USC 102 Novelty (BERT): 0.5565386373222229
- Combined Prediction Score: 0.8123873833066693
- Mean Citation Score: 419.35991
- Max Citation Score: 448.797
- Similarity Product: 325.4951628921032

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test